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Abstract. Despite the high efficiency and broad scope 
of chiral iridium(N,P ligand) complexes as catalysts for 
asymmetric hydrogenation, the problem of catalyst 
recovery and recycling has so far attracted little 
attention. We have found that at the end of a 
hydrogenation reaction, iridium(N,P ligand) catalysts 
form dimeric Ir(III) dihydride complexes, which can be 
converted back to the original precatalysts by addition 
of COD. Based on these findings, a practically simple 
protocol for catalyst recovery was devised. The 
recovered complexes showed essentially the same 
reactivity and enantioselectivity as the original 
catalysts. Especially large-scale applications and 
hydrogenations of less reactive substrates that require 
high catalyst loadings will benefit from this protocol 
that allows recovery and reuse of expensive iridium 
complexes. 
Keywords: iridium · N,P ligands · asymmetric 
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Iridium complexes derived from chiral N,P ligands 
have emerged as highly effective catalysts for the 
asymmetric hydrogenation of a wide range of 
functionalized as well as unfunctionalized alkenes, 
furans, and imines.[1] In contrast to rhodium- and 
ruthenium-diphosphine catalysts,[2] they show high 
reactivity and enantioselectivity towards C=C bonds 
lacking adjacent coordinating groups and, therefore, 
have significantly broadened the application range of 
asymmetric hydrogenation. 
For large-scale reactions, especially with less 
reactive substrates that require high catalyst loadings, 
procedures for catalyst recycling would be desirable. 
Although the development of strategies for recovery 
and recycling of homogenous catalysts is an active 
field of research since many years,[3] the recovery of 
iridium(N,P ligand) complexes after hydrogenation is 
essentially unexplored. Only Börner and co-
workers[4] reported a recycling protocol using 
propylene carbonate as solvent. After hydrogenation 
the product was extracted from the reaction medium 
with hexane while the catalyst remained in the 
propylene carbonate layer. However, the scope of this 
protocol is limited. Reaction rates in propylene 
carbonate were significantly lower than in CH2Cl2, 
resulting in much longer reaction times and in some 
cases in incomplete conversion, even though only 
very reactive terminal alkenes were investigated. 
Solubility issues further restrict application, as the 
product must be soluble in hexane and possess a 
partition coefficient that allows extraction from 
propylene carbonate. 
A general problem making catalyst recovery 
difficult is the instability of the catalytically active Ir 
complexes present in the reaction medium.[5] 
Although Ir(N,P ligand)(COD) complexes (e.g. 1 in 
Scheme 1), which serve as precatalysts, are stable 
against oxygen and moisture and can be purified by 
chromatography on silica gel, however, the active 
species resulting from reaction with dihydrogen are 
too reactive to be isolated. Thus, in order to recover 
the catalyst, the Ir complexes present in the reaction 
medium after hydrogenation must be converted into 
stable compounds that survive workup and can be 
used as precatalysts in a subsequent hydrogenation 
reaction. Here we report a procedure that allows 
catalyst recovery as COD complex, which displays 
the same reactivity and enantioselectivity as the 
original precatalyst. 
The incentive to develop such a procedure came 
from our mechanistic and structural studies of Ir-
hydride complexes. NMR experiments revealed that 
under hydrogenation conditions the resting state in 
the catalytic cycle is a cationic mononuclear 
iridium(III)-dihydride alkene complex 
([IrIII(H)2(alkene)(N,P)]+).[5c] In the absence of an 
alkene substrate, dimeric Ir(III)-dihydride complexes 
such as 2 are observed (Scheme 1).[5b] 
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Scheme 1. Selective formation of the dinuclear iridium(III) 
hydride complex 2 in the presence of [H(OEt2)2]BArF.[5b] 
These complexes are unstable and exhibit a strong 
tendency to aggregate further to irreversibly form 
catalytically inactive trinuclear polyhydride clusters. 
In a preparative experiment the Ir(PHOX) complex 3 
was converted to the trinuclear complex 4 in high 
yield upon treatment with dihydrogen (Eq. 1).[6] 
Formation of such polyhydride clusters was found to 
be responsible for catalyst deactivation during 
hydrogenation reactions using complexes with 
hexafluorophosphate as counterion. With BArF (BArF 
= tetrakis[3,5-bis(trifluoromethyl)phenyl]borate) and 
related extremely weakly coordinating anions 
practically no catalyst deactivation was observed 
anymore, so high turnover numbers became 
possible.[7] However, in the absence of an alkene 
substrate, formation of trinuclear complexes was still 
observed.[5b]  
All efforts to convert complex 4 back into an 
catalytically active species failed,[6] implying that the 
only way to prevent catalyst deactivation is to 
suppress the formation of polyhydride clusters. We 
recently found that in the absence of an alkene or 
other coordinating species, iridium complex 1 was 
converted almost quantitatively (>95%) to the 
dimeric Ir-hydride complex 2 upon treatment with H2 
in the presence of [H(OEt2)2]BArF (Scheme 1).[5b] 
Under these acidic conditions, no formation of 
trinuclear clusters occurred, which according to eq. 1 
requires abstraction of a proton from an Ir-hydride 
intermediate. Complex 2 could be isolated and 
characterized by NMR and single crystal X-ray 
analysis. Notably, this dimeric hydride complex 
showed catalytic activity in the hydrogenation of 
unfunctionalized olefins; the conversion and 
enantioselectivity were only slightly lower than with 
the mononuclear precatalyst 1.[5b] Apparently, 
complex 2 was converted to an active catalyst under 
hydrogenation conditions.[8] We assumed that under 
the action of an alkene substrate, dissociation of the 
dimer and formation a monomeric Ir(alkene) complex 
occurred, which had been previously characterized as 
a catalytic intermediate.[5c]  
Based on the observation that under acidic 
conditions no formation of trinuclear clusters was 
observed, initial hydrogenation experiments were 
performed with catalyst 1 in the presence of an acid. 
However, addition of [H(OEt2)2]BArF, even in 
catalytic amounts, had a deleterious effect on the 
selectivity.[9]  
Assuming that the rate of conversion to inactive 
trinuclear clusters varies with the ligand structure due 
to different electronic and/or steric factors, we 
investigated whether dimeric Ir(III) dihydride 
complexes derived from other N,P ligands are less 
prone to form inactive trinuclear clusters in the 
absence of substrate under hydrogen gas. Initial 
hydrogenation experiments with several N,P iridium 
complexes under hydrogen gas in CD2Cl2 revealed 
that the pyridine-based complexes 5 and 6 do not 
form trinuclear complexes. These complexes are very 
efficient catalysts for the asymmetric hydrogenation 
of unfunctionalized olefins, in particular complex (S)-
5 showed excellent results in the hydrogenation of 
vitamin E side chain precursors and γ-tocotrienyl 
acetate (Scheme 2).[10] 
 
Scheme 2. Examples of pyridine-based iridium complexes 
and application of complex (S)-5 in the hydrogenation of 
-tocotrienyl acetate. 
Treatment of complex 5 with 50 bar of hydrogen 
gas at room temperature in CD2Cl2 for 2 hours 
afforded a new species. Even after longer reaction 
times under hydrogen gas no significant 
decomposition of this species or conversion to a 
polynuclear cluster was observed. The 1H and 31P 
NMR spectra showed that a single complex had been 
formed almost exclusively. Based on extended 2D 
NMR studies its structure was assigned as the 
dinuclear iridium hydride complex 7, bearing in total 
four hydrides, two bridging hydrides (Ha and Hb) 
and two terminal hydrides (Ht) (Figure 1). The 1H 
NMR spectrum displayed at triplet at -3.32 ppm and a 
multiplet at -26.98 ppm for the bridging hydrides Ha 
and Hb, and a broad singlet at -30.93 ppm for the 
terminal hydrides, respectively. The 2J(H,P) values of 
80 Hz for Ha and 23 Hz for Hb are in agreement 
with structure 7. The low frequency shift of the 
terminal hydride is characteristic for a structure with 
a hydride ligand positioned trans to a coordination 
site which is either vacant or engaged in a C-H 
agostic interaction or loosely bound to a weakly 
coordinating ligand such as a dichloromethane 
molecule.[11] The assigned dimeric structure possesses 
C2 symmetry with the two phosphorus atoms oriented 
in a syn-arrangement. Consequently, the 31P{1H} 
NMR spectrum showed a singlet at 86.3 ppm.  
In addition, a small amount of a different hydride 
species was observed (see Figure 1). NOESY 
experiments revealed that this species is in rapid 
equilibrium with complex 7. We interpret this finding 
as an indication that the minor species is a 
mononuclear iridium dihydride complex, which is 
formed by partial reversible dissociation of the 
corresponding dimer 7.[8] 
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Figure 1. Section of the hydride region showing the 
hydrides signals of the dinuclear iridium hydride complex 
7 and the minor species (*), respectively (R = o-Tol, L = 
CD2Cl2; 295 K, 500 MHz, CD2Cl2). 
Treatment of complex 6 with 50 bar of hydrogen 
gas at room temperature in CD2Cl2 for 2 hours also 
afforded a new major species with a dynamic 
structure in solution as indicated by the broadened 
signals. The 1H NMR spectrum showed two broad 
hydride signals at -17.64 and -32.51 ppm in a 1:1 
ratio. The 31P{1H} NMR spectrum revealed a broad 
signal at 136.6 ppm (compared to 141.8 ppm for the 
COD-precursor). The dynamic nature of this species 
precluded the elucidation of its structure (monomeric 
or dimeric form), however, based on the NMR data 
the formation of a trinuclear cluster could be clearly 
excluded. 
Based on these results, we assumed that after 
consumption of the substrate, the pyridine-based 
catalysts would again be present as dimeric or 
monomeric species, which upon addition of COD 
could be converted back to the stable COD 
complexes used as precatalysts. Indeed, addition of 
COD to the dinuclear iridium hydride complex 7 
resulted in complete and clean regeneration of 
complex 5 (based on NMR analysis), that could be 
isolated in 84% yield on a 25 mg scale (Scheme 3). 
Scheme 3. Regeneration of pyridine-based iridium 
complex 5 by the addition of COD. 
This promising result prompted us to test this 
approach for recovering the catalyst from the reaction 
mixture resulting from the hydrogenation of an 
alkene. Accordingly, the following protocol, which 
represents a slight modification of a typical 
hydrogenation procedure, was devised: 1) The 
substrate was stirred in the presence of 1.0 mol% 
iridium catalyst under 50 bar hydrogen gas for 
2 hours; 2) After release of hydrogen gas, 0.1 equiv 
of COD was added and the reaction mixture was 
stirred for 1 hour followed by evaporation of the 
solvent; 3) The residue was separated by a simple 
filtration over a short plug of silica gel. First the 
substrate and the excess of COD were eluted with a 
mixture of pentane/Et2O (1/1), followed by washing 
the silica gel plug with CH2Cl2 to obtain the 
recovered iridium complex. The excess of COD was 
removed from the hydrogenation product under 
reduced pressure (Scheme 4). 
Scheme 4. Protocol applied for the recovery of iridium 
COD complexes from hydrogenation reactions. 
Following this protocol, we have performed the 
hydrogenation of (E,E)-farnesyl acetone (8), a 
possible precursor in the synthesis of vitamin E, on a 
665 mg scale with 1 mol% of catalyst 5 (40 mg). 
Catalyst 5 was recovered in 70% yield after the 
hydrogenation reactions and the fully saturated alkyl 
ketone was isolated in 99% yield (entry 1 of Table 1). 
Table 1. Recovery of different hydrogenation catalysts 
from the reaction mixture. 
[a] Reaction conditions: 50 bar H2 pressure, 1.0 mol% 
catalyst, CH2Cl2 (0.2 M), room temperature, 2 h reaction 
time. [b] Full conversion was obtained for all entries; 
isolated yields of the hydrogenated products were >95%. 
[c] 2.50 mmol substrate used. [d] 1.97 mmol substrate used. 
[e] 1.93 mmol substrate used. [f] 1.45 mmol substrate used. 






















To evaluate whether the recovery protocol is also 
applicable to other Ir(N,P ligand) catalysts, we 
carried out experiments with catalyst 6, PHOX 
catalyst 9, and the commercially available 
ThrePHOX catalyst 10. For these studies (E)-1,2-
diphenyl-1-propene (11) was used as substrate, since 
(E,E)-farnesyl acetone shows reduced conversion or 
selectivity with these catalysts. Catalyst 6 was 
recovered in 60% yield from the hydrogenation 
reaction (entry 2). This result is in accordance with 
the previous observation that catalyst 6 does not form 
a trinuclear cluster under hydrogen gas (vide supra). 
Remarkably, the same protocol also enabled recovery 
of the PHOX complex 9 in 67% yield, despite the fact 
that this catalyst is prone to form a trinuclear 
complex[6] in the absence of substrate (entry 3). In 
contrast, the ThrePHOX catalyst 10 could not be 
recovered by this procedure (entry 4). 
To compare the enantioselectivity and reactivity of 
the parent and the recovered catalyst, the PHOX-
based complexes 9 and 9re (recovered catalyst) were 
applied in the hydrogenation of (E)--diphenyl-1-
propene (11). The results revealed virtually no 
difference between the parent and recovered catalyst. 
At 1.0 and 0.2 mol% catalyst loading identical 
enantiomeric excesses were observed and also the 
conversion was essentially the same (Table 2).  
Table 2. Hydrogenation with original catalyst 9 and a 
recovered catalyst 9re.  






1 9 1 >99 86 (R) 
2 9re 1 >99 86 (R) 
3 9 0.2 37 87 (R) 
4 9re 0.2 40 87 (R) 
[a] Reaction run on 0.1 mmol scale. [b] Determined by GC 
analysis. [c] Determined by HPLC analysis on a chiral 
stationary phase. 
In conclusion, NMR studies have demonstrated 
that at the end of a hydrogenation reaction 
iridium(N,P ligand) catalysts form dimeric Ir(III) 
dihydride complexes after the substrate has been 
consumed. The stability of these complexes strongly 
depends on the ligand structure. While hydride 
complexes derived from phosphinooxazoline 
complexes such as 9 and 10 are irreversibly 
converted to catalytically inactive trinuclear Ir 
clusters after prolonged reaction times, pyridine-
based ligand complexes derived from 5 and 6 do not 
form such deactivation products and remain in 
solution as catalytically active Ir(III)-dihydride 
dimers. Upon addition of COD the original 
precatalysts 5 and 6 are regenerated. Based on these 
findings we have devised a practically simple 
protocol that allows recovery of the catalyst in high 
purity in 60-70% yield. Importantly, the recovered 
COD complex exhibited the same activity and 
enantioselectivity as the original precatalyst. 
Unexpectedly, the protocol also worked well for 
Ir(PHOX) complex 9, despite its propensity to form 
inactive Ir clusters. On the other hand, the 
Ir(ThrePHOX) catalyst 10 could not be recovered. 
Although this protocol does not seem applicable to all 
catalysts, it should be of practical value considering 
the promising results obtained with pyridine-based 
ligand complexes, which are the catalysts of choice 
for many important substrate classes. Especially 
large-scale applications and hydrogenations of less 
reactive substrates that require high catalyst loadings 
will benefit from this protocol that allows recovery 




Procedure for the hydrogenation of (E,E)-farnesyl acetone 
(8) and subsequent recovery of catalyst 5: A glass inlet of 
an autoclave was charged with iridium catalyst 5 (40 mg, 
1.0 mol%) and then (5E,9E)-farnesylacetone (8, 656 mg, 
2.50 mmol) dissolved in CH2Cl2 (12.5 mL, 0.2 M) was 
added under normal atmosphere. The glass inlet was 
placed in an autoclave that was purged with argon and then 
pressurized to 50 bar with H2. The reaction mixture was 
stirred for 2 h at room temperature (magnetic stir bar, 
700 rpm). The autoclave was opened under normal 
atmosphere and the reaction mixture was transferred to a 
round bottom flask, which had been previously purged 
with argon for 5 min. 1,5-Cyclooctadiene (0.1 equiv.) was 
added and the reaction mixture was stirred for 1 h at room 
temperature under argon. All volatiles were evaporated 
under reduced pressure (700 mbar  10 mbar, 40 °C), 
whereby most of the COD was removed. The residue was 
purified by column chromatography (silica gel d × h: 2 cm 
× 8 cm) by first eluting the hydrogenated product with 
Et2O/pentane (1/1) (~100 mL), followed by eluting the 
catalyst with CH2Cl2 (~60 mL). The separate fractions 
were concentrated in a rotary evaporator (700 mbar  10 
mbar, 40 °C) and dried under high-vacuum (~10-1 mbar, 30 
min, rt) to afford the hydrogenated product free of COD in 
99% yield (663 mg) and the recovered catalyst 5 in 70% 
yield (28 mg), respectively. 
Procedure for the hydrogenation (E)-1,2-diphenyl-1-
propene (11) and subsequent recovery of catalyst 6: A 
glass inlet of an autoclave was charged with iridium 
catalyst 6 (30 mg, 1.0 mol%) and then (E)-1,2-diphenyl-1-
propene (11, 382 mg, 1.97 mmol) dissolved in CH2Cl2 (10 
mL, 0.2 M) was added under normal atmosphere. The glass 
inlet was placed in an autoclave that was purged with 
argon and then pressurized to 50 bar with H2. The reaction 
mixture was stirred for 2 h at room temperature (magnetic 
stir bar, 700 rpm). The autoclave was opened under normal 
atmosphere and the reaction mixture was transferred to a 
round bottom flask, which had been previously purged 
with argon for 5 min. 1,5-Cyclooctadiene (0.1 equiv) was 
added and the reaction mixture was stirred for 1 h at room 
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temperature under argon. All volatiles were evaporated 
under reduced pressure (700 mbar  10 mbar, 40 °C), 
whereby most of the COD was removed. The residue was 
purified by column chromatography (silica gel d × h: 2 cm 
× 5 cm) by first eluting the hydrogenated product with 
Et2O/pentane (1/1) (~100 mL), followed by eluting the 
catalyst with CH2Cl2 (~40 mL). The separate fractions 
were concentrated in a rotary evaporator (700 mbar  10 
mbar, 40 °C) and dried under high-vacuum (~10-1 mbar, 30 
min, rt) to afford the hydrogenated product free of COD in 
99% yield (381 mg) and the recovered catalyst 6 in 60% 
yield (18.1 mg), respectively. 
For the hydrogenation of (E)-1,2-diphenyl-1-propene (11) 
with catalysts 9 and 10 and recovery of those, the same 
procedure as described for catalyst 6 was applied, using 
1.93 mmol and 1.45 mmol, respectively, of (E)-1,2-
diphenyl-1-propene (11).  
The analytical data of the recovered catalyst 5,[12] 6,[12] and 
9[13] and the hydrogenation products propane-1,2-
diyldibenzene[14] and (6R,10R)-6,10,14-
trimethylpentadecan-2-one[15] are consistent with literature 
values. 
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